✦ LIBER ✦

P4-392: The efficacy of souvenaid™ in mild Alzheimer's disease: Design of a randomized, controlled, double-blind, parallel group, multicentre, multicountry clinical trial

✍ Scribed by Scheltens, Philip; Verhey, Frans R.J.; Olde Rikkert, Marcel G.M.; Kamphuis, Patrick J.; Wilkinson, David; Kurz, Alexander

Book ID: 122424453
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 49 KB
Volume: 4
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2008.05.2462

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized, Double-Blind Multicentre C

A Randomized, Double-Blind Multicentre Clinical Trial Comparing the Efficacy of Calcium Dobesilate with Placebo in the Treatment of Chronic Venous Disease

✍ M.J. Martínez-Zapata; R.M. Moreno; I. Gich; G. Urrútia; X. Bonfill; on behalf of 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 241 KB

P4-405: A multinational, randomized, dou

P4-405: A multinational, randomized, double-blind, placebo-controlled, parallel-group trial of memantine extended-release capsule (28 mg, once daily) in patients with moderate to severe Alzheimer's disease

✍ Grossberg, George; Manes, Facundo; Allegri, Ricardo; Gutierrez Robledo, Luis Mig 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Study of the ketogenic agent AC-1202 in

Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial

✍ Samuel T Henderson; Janet L Vogel; Linda J Barr; Fiona Garvin; Julie J Jones; La 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 640 KB

A topical microemulsion for the preventi

A topical microemulsion for the prevention of allergic rhinitis symptoms: results of a randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares study)

✍ Ojeda, Pedro; Piqué, Núria; Alonso, Alicia; Delgado, Julio; Feo, Francisco; Igea 📂 Article 📅 2013 🏛 BC Decker 🌐 English ⚖ 194 KB

A multicentre, randomized, double-blind,

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre

Efficacy of a fixed combination of indom

Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine in the treatment of episodic tension-type headache: a double-blind, randomized, nimesulide-controlled, parallel group, multicentre trial

✍ R. Cerbo; V. Centonze; I. Grazioli; B. Tavolato; T. Trenti; C. Uslenghi; E. Ster 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB